Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hydrocortisone (ViaDerma, Inc.)
- Development stage
- Unknown
- Lead developer
- ViaDerma
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical, Transdermal
01
Overview
Calm is a topical anti-inflammatory formulation developed by **ViaDerma**, utilizing the proprietary **SkinPass™** transdermal delivery technology. The active ingredient is **hydrocortisone** (1%), a small molecule corticosteroid that provides temporary relief from itching and inflammation associated with minor skin irritations, such as eczema, psoriasis, and seborrheic dermatitis. The SkinPass™ technology is a patent-pending delivery system designed to enhance medication absorption through the skin, driving the active drug deep into damaged tissue to treat inflammation at its root while minimizing the systemic side effects typically associated with oral steroids. It is available as an over-the-counter (OTC) product in both ointment and solution forms.
- Brand names
- CalmViaDerma Calm Anti-Itch
- Other names
- Calm Anti-ItchViaDerma Calm
02
Targets
GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)
Beyond the preview
Go deeper on hydrocortisone (ViaDerma, Inc.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hydrocortisone (ViaDerma, Inc.).